Drug Profile
Evodiamine
Alternative Names: Wu-Chu-YuLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Mitsubishi Chemical
- Class Heart failure therapies; Quinazolines; Small molecules
- Mechanism of Action Adenosine triphosphatase inhibitors; Calcium channel antagonists; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 19 Jul 1996 New profile
- 19 Jul 1996 Discontinued-Preclinical for Heart failure in Japan (Unknown route)